|
| Status |
Public on Jun 01, 2020 |
| Title |
AVAglio_GSM2225369 |
| Sample type |
RNA |
| |
|
| Source name |
AVAglio_GSM2225369
|
| Organism |
Homo sapiens |
| Characteristics |
age: 65
Sex: Male
corticosteroids: Off
surgical status: Total resection
treatment: Bevacizumab
phillips subtype: Proneural
tcga subtype: Proneural
kps: 90-100
mmse: >=27
rpa: Grade IV
os (diagnosis): 14.09
os cnsr (event = 1, censor = 0): 1
mgmt status: Missing
|
| Treatment protocol |
Not applicable
|
| Growth protocol |
Not applicable
|
| Extracted molecule |
total RNA |
| Extraction protocol |
Not applicable
|
| Label |
Nucleotide/fluorophore barcode
|
| Label protocol |
Per NanoString Total RNA Standard Protocol for formalin-fixed, paraffin-embedded (FFPE) samples.
|
| |
|
| Hybridization protocol |
Per NanoString Total RNA Standard Protocol for formalin-fixed, paraffin-embedded (FFPE) samples.
|
| Scan protocol |
Per NanoString Total RNA Standard Protocol for formalin-fixed, paraffin-embedded (FFPE) samples.
|
| Data processing |
Blanks were not available for the AVAglio dataset, as a result background correction was implemented using global negative control probes. Sample-wise normalization was performed by transforming counts to the log2 scale and subtracting the sample-wise mean of housekeeping genes.
Water samples (used for the normalisation) using the NanoStringQCPro package on Bioconductor.
|
| |
|
| Submission date |
May 14, 2020 |
| Last update date |
Jun 02, 2020 |
| Contact name |
Radia Johnson |
| Organization name |
Genentech
|
| Street address |
1 DNA Way
|
| City |
South San Francisco |
| State/province |
CA |
| ZIP/Postal code |
94080 |
| Country |
United Kingdom |
| |
|
| Platform ID |
GPL28485 |
| Series (2) |
| GSE150604 |
Development of a gene expression-based prognostic signature for IDH wild-type glioblastoma [AVAglio] |
| GSE150615 |
Development of a gene expression-based prognostic signature for IDH wild-type glioblastoma |
|
| Relations |
| Reanalysis of |
GSM2225369 |
